Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/1998
06/18/1998WO1998026069A1 Methods and compositions for identifying morphogen analogs
06/18/1998WO1998026068A1 Human apoptosis-related calcium-binding protein
06/18/1998WO1998026067A1 Adipocyte-specific differentiation-related protein
06/18/1998WO1998026066A1 Expression of proteins for treating asthma via ligand mediated activation of their encoding genes
06/18/1998WO1998026063A1 Nur-re a response element which binds nur nuclear receptors and method of use therefor
06/18/1998WO1998026062A2 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them
06/18/1998WO1998026056A1 Protein phosphatase regulatory subunit
06/18/1998WO1998026052A1 Tryparedoxin peroxidase
06/18/1998WO1998026051A2 Tryparedoxin, expression plasmid, process of production, use, test system and pharmaceutical preparation
06/18/1998WO1998026050A2 Glutathionylspermidine synthetase
06/18/1998WO1998026047A1 Methods and compositions for identifying morphogen analogs
06/18/1998WO1998026046A2 A novel transcription factor expressed in cycling cells, nucleic acid molecules encoding said transcription factor and its promoter region and uses thereof
06/18/1998WO1998025970A1 Antithrombotic peptides derived from fibronectin type ii repeats
06/18/1998WO1998025968A1 Novel forms of class ii mhc transactivator (ciita)
06/18/1998WO1998025966A1 Use of polypeptides for treating thrombocytopenia
06/18/1998WO1998025965A2 Peptides and compounds that bind to the thrombopoietin receptor
06/18/1998WO1998025964A1 Submucosa extracts
06/18/1998WO1998025963A1 Analysis and separation of platelet-derived growth factor proteins
06/18/1998WO1998025962A2 Secreted proteins and polynucleotides encoding them
06/18/1998WO1998025961A1 Antimicrobially active polypeptides
06/18/1998WO1998025960A1 Sequences derived from the genome of the c hepatitis virus, and use thereof
06/18/1998WO1998025956A2 Human gtp-binding proteins
06/18/1998WO1998025953A1 Antimicrobial cationic peptides
06/18/1998WO1998025951A1 Inhibitors of peptide binding to mhc class ii proteins
06/18/1998WO1998025950A1 Polyprolyl inhibitors of cyclophilin
06/18/1998WO1998025949A1 Substituted 5-amino-1,3,4-thiadiazole-2-thiones
06/18/1998WO1998025946A1 Monoclonal antibodies specific to endothelial cell cadherins and uses thereof
06/18/1998WO1998025647A1 Calcium-independent modulation by cd81 of receptor signalling
06/18/1998WO1998025645A1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene
06/18/1998WO1998025644A1 Compositions and methods for enhancing intestinal function
06/18/1998WO1998025643A2 Neuropeptides as modulators for cell differentiation and proliferation
06/18/1998WO1998025642A2 Pharmaceutical formulations comprising a water-insoluble complex for sustained drug delivery
06/18/1998WO1998025641A1 MEDICAL USES OF scuPA/suPAR COMPLEX
06/18/1998WO1998025640A2 Novel methods for testing inhibitors of paired helical filaments and uses for treatment of alzheimer's disease
06/18/1998WO1998025639A1 HYPOGLYCEMIC AGENTS FROM HARUNGANA OR $i(VISMIA SPP.)
06/18/1998WO1998025634A1 Serum-derived factor inducing cell differentiation and medical uses thereof
06/18/1998WO1998025630A1 Transaldolase-mediated regulation of apoptosis
06/18/1998WO1998025597A2 Method for treating and preventing heart failure and ventricular dilatation
06/18/1998WO1998025589A1 Active agent transport systems
06/18/1998WO1998025457A1 Composition and method for preserving progenitor cells
06/18/1998WO1998018919A3 GABAa Receptor subunit epsilon-related protein
06/18/1998WO1998018826A3 Anti-CCR5 antibodies and methods of use therefor
06/18/1998WO1998016523A3 Selective factor xa inhibitors
06/18/1998WO1998013385A3 Non-naturally occurring lipoprotein particle
06/18/1998WO1998013024A3 Hyaluronic drug delivery system
06/18/1998WO1998009644A3 Method for lowering cholesterol levels
06/18/1998WO1998008956A3 Use of a mutated macrolide binding protein for the prevention of gvhd
06/18/1998WO1998006742A3 Peptides for treatment of inflammation and shock
06/18/1998WO1998006431A3 Method for treating diabetes
06/18/1998WO1998005361A3 Long-acting drugs and pharmaceutical compositions comprising them
06/18/1998WO1998003194A3 Substance p treatment for immunostimulation
06/18/1998WO1998000535A3 Method for inhibiting hiv-1 infection, drug screens, and methods of diagnosis and prognosis of susceptibility to hiv infection
06/18/1998DE19727815C1 Monoclonal antibody specific for CD164
06/18/1998DE19727813C1 Monoclonal antibody specific for CD164
06/18/1998DE19652586A1 Dhc-Peptid und Mittel Dhc-peptide and means
06/18/1998DE19652033A1 Neuropeptid (CGRP) als Modulator zur Zelldifferenzierung und Proliferation Neuropeptide (CGRP) as a modulator of cell differentiation and proliferation
06/18/1998CA2621857A1 Peptides and compounds that bind to a receptor
06/18/1998CA2276094A1 Antimicrobially active polypeptides
06/18/1998CA2275340A1 Fusion protein comprising the whole or part of the pp65 protein of human cmv, useable in particular for preparing a vaccine
06/18/1998CA2275177A1 Tryparedoxin peroxidase
06/18/1998CA2275175A1 Tryparedoxin, expression plasmid, process of production, use, test system and pharmaceutical preparation
06/18/1998CA2274847A1 Pharmaceutical formulations for sustained drug delivery
06/18/1998CA2274837A1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene
06/18/1998CA2274739A1 Human apoptosis-related calcium-binding protein
06/18/1998CA2274735A1 Human gtp-binding proteins
06/18/1998CA2274728A1 Adipocyte-specific differentiation-related protein
06/18/1998CA2274515A1 Glutathionylspermidine synthetase
06/18/1998CA2274507A1 Secreted proteins and polynucleotides encoding them
06/18/1998CA2274500A1 Bone stimulating factor
06/18/1998CA2274477A1 Medical uses of scupa/supar complex
06/18/1998CA2274142A1 Antithrombotic peptides derived from fibronectin type ii repeats
06/18/1998CA2274102A1 Expression of proteins for treating asthma via ligand mediated activation of their encoding genes
06/18/1998CA2263886A1 Method for treating and preventing heart failure and ventricular dilatation
06/18/1998CA2263828A1 Polyprolyl inhibitors of cyclophilin
06/18/1998CA2245956A1 Monoclonal antibodies specific to endothelial cell cadherins and uses thereof
06/17/1998EP0848064A1 New antibiotic, Feglymycine, process for its preparation and use of the same
06/17/1998EP0848063A2 Nucleic acid constructs containing hybrid promotors for use in gene therapy
06/17/1998EP0848062A2 Aspartic protease ASP1
06/17/1998EP0848061A2 Self-enhancing, pharmacologically controllable expression systems
06/17/1998EP0848060A2 Novel human 11CB splice variant
06/17/1998EP0848013A1 NM03, a monoclonal antibody to HIV-1 gp120 protein
06/17/1998EP0848012A1 Use of polypeptides for treating thrombocytopenias
06/17/1998EP0847757A1 Medicine comprising hgf gene
06/17/1998EP0847530A1 QUANTITATION OF p97 TO DIAGNOSE AND MONITOR ALZHEIMER'S DISEASE
06/17/1998EP0847452A1 Fluorescence resonance energy transfer screening assay for the identification of hiv-1 envelope glycoprotein-medicated cell
06/17/1998EP0847443A1 Crystalline zap family proteins
06/17/1998EP0847402A1 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor
06/17/1998EP0847401A1 Dna sequence coding for a polypeptide which enhances virus infection of host insects
06/17/1998EP0847400A1 Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin
06/17/1998EP0847278A1 Analogs of parathyroid hormone
06/17/1998EP0847277A1 Treatment of ocular inflammatory conditions with interleukin-10
06/17/1998EP0847272A2 LIPOSOMAL PHOSPHODIESTER, PHOSPHOROTHIOATE, AND p-ETHOXY OLIGONUCLEOTIDES
06/17/1998EP0745124B1 Mammalian cell cycle protein
06/17/1998EP0689549B1 New urea derivates, their preparation and their use
06/17/1998EP0636142B1 Lactam peptides having hle inhibiting activity
06/17/1998EP0633765B1 Skin care method and composition
06/17/1998EP0611376B1 Production and use of multimeric hemoglobins
06/17/1998EP0575452B1 Method for production of a vegetable protein hydrolyzate
06/17/1998EP0500745B1 Metal-peptide compositions and cosmetic methods for stimulating hair growth
06/17/1998EP0448704B1 Osteogenic devices
1 ... 2615 2616 2617 2618 2619 2620 2621 2622 2623 2624 2625 2626 2627 2628 2629 2630 2631 2632 2633 2634 2635 ... 3163